On November 4, 2021, Orchard Therapeutics (NASDAQ: ORTX) reported disappointing Q3 GAAP Ruslts with EPS and Revenue missed estimates. Goi...

On March 15, 2022, Esperion Therapeutics (NASDAQ: ESPR) announced that the Company’s CFO, Richard B. Bartram was stepping down from his p...

I sold our house in May 2022. Shortly after I put the tax money into Gemeni EARN because...why not? The Winkelvos twins were involved, ...

On May 24, 2022, Genocea Biosciences (NASDAQ: GNCA) announced that its Board of Directors voted to wind down the Company's ongoing operat...

On January 19, 2022, UCB (Euronext: UCB) and Zogenix (NASDAQ: ZGNX) announced that the companies have entered into a definitive agreement...

On June 27, 2022, Ipsen (Euronext: IPN; ADR: IPSEY) and Epizyme (Nasdaq: EPZM) announced that they have entered into a definitive merger ...

On March 1, 2022, Karyopharm Therapeutics (KPTI) plunged after negative feedback from the FDA on its supplemental New Drug Application su...

On December 7, 2022, Bloomberg reported that Daniel Loeb’s Third Point sold its stake in Cano Health Inc. (CANO) amid mounting concerns a...

On November 16, 2022, Singularity Future Technology Ltd. (SGLY) disclosed that “The Company has received subpoenas from the US Attorney’s...

On December 16, 2021, the Consumer Financial Protection Bureau announced that it had launched an inquiry into Affirm’s BNPL payment servi...

On July 26, 2022, F45 (FXLV) reported several material negative facts: significantly reduced its financial guidance, disclosed that woul...

On November 2, 2022, Iris Energy (IREN) disclosed that “certain equipment (i.e., Bitcoin miners) currently produce insufficient cash flow...

On October 18, 2022, the SEC announced that it was taking legal action against NewAge’s former CEO, Brent Willis. The SEC alleged that he...

On April 27, 2022, NeoGenomics (NEO) disclosed & admitted material negative facts: “higher payroll and payroll related costs” which drov...

On September 22, 2022, the FDA Oncologic Drugs Advisory Committee(ODAC) voted 9-4 not to recommend Spectrum's (SPII) poziotinib for Accel...

On July 11, 2022, Gap Inc (GPS) announced that Syngal was stepping down from her position as President and CEO of the Company, and resign...

On November 9, 2022, the FDA Pulmonary-Allergy Drugs Advisory Committee voted against granting Veru’s EUA request for sabizabulin. One Co...